Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

A new painkiller was approved by the Food and Drug Administration (FDA) on Thursday, and is one step closer to making its way ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

There are five drugs available in the USA with class-1 studies for PAM – propranolol ... see aspirin dosage Acetaminophen 250 mg + aspirin 250 mg + caffeine 65 mg Excedrin® migraine ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

Approval of Journavx for acute pain marks the first new class of acute pain medication approved by the FDA in over 20 years.

Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain ...

So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the Misuse of Drugs to “carefully consider” the issue. Do you think ...

If a triptan is ineffective, a different one should be tried before switching to a different class of drugs. Recent data ... see aspirin dosage Acetaminophen 250 mg + aspirin 250 mg + caffeine ...